↓ Skip to main content

Novel Murine Dendritic Cell Lines: A Powerful Auxiliary Tool for Dendritic Cell Research

Overview of attention for article published in Frontiers in immunology, January 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

twitter
2 X users

Readers on

mendeley
291 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Novel Murine Dendritic Cell Lines: A Powerful Auxiliary Tool for Dendritic Cell Research
Published in
Frontiers in immunology, January 2012
DOI 10.3389/fimmu.2012.00331
Pubmed ID
Authors

Silvia A. Fuertes Marraco, Frédéric Grosjean, Anaïs Duval, Muriel Rosa, Christine Lavanchy, Devika Ashok, Sergio Haller, Luc A. Otten, Quynh-Giao Steiner, Patrick Descombes, Christian A. Luber, Felix Meissner, Matthias Mann, Lajos Szeles, Walter Reith, Hans Acha-Orbea

Abstract

Research in vitro facilitates discovery, screening, and pilot experiments, often preceding research in vivo. Several technical difficulties render Dendritic Cell (DC) research particularly challenging, including the low frequency of DC in vivo, thorough isolation requirements, and the vulnerability of DC ex vivo. Critically, there is not as yet a widely accepted human or murine DC line and in vitro systems of DC research are limited. In this study, we report the generation of new murine DC lines, named MutuDC, originating from cultures of splenic CD8α conventional DC (cDC) tumors. By direct comparison to normal WT splenic cDC subsets, we describe the phenotypic and functional features of the MutuDC lines and show that they have retained all the major features of their natural counterpart in vivo, the splenic CD8α cDC. These features include expression of surface markers Clec9A, DEC205, and CD24, positive response to TLR3 and TLR9 but not TLR7 stimuli, secretion of cytokines, and chemokines upon activation, as well as cross-presentation capacity. In addition to the close resemblance to normal splenic CD8α cDC, a major advantage is the ease of derivation and maintenance of the MutuDC lines, using standard culture medium and conditions, importantly without adding supplementary growth factors or maturation-inducing stimuli to the medium. Furthermore, genetically modified MutuDC lines have been successfully obtained either by lentiviral transduction or by culture of DC tumors originating from genetically modified mice. In view of the current lack of stable and functional DC lines, these novel murine DC lines have the potential to serve as an important auxiliary tool for DC research.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 291 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Sweden 1 <1%
Poland 1 <1%
France 1 <1%
Unknown 287 99%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 64 22%
Researcher 55 19%
Student > Master 35 12%
Student > Bachelor 35 12%
Student > Doctoral Student 13 4%
Other 32 11%
Unknown 57 20%
Readers by discipline Count As %
Agricultural and Biological Sciences 70 24%
Immunology and Microbiology 54 19%
Biochemistry, Genetics and Molecular Biology 53 18%
Medicine and Dentistry 18 6%
Chemistry 7 2%
Other 25 9%
Unknown 64 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 December 2012.
All research outputs
#16,721,717
of 25,374,647 outputs
Outputs from Frontiers in immunology
#18,323
of 31,520 outputs
Outputs of similar age
#168,822
of 250,100 outputs
Outputs of similar age from Frontiers in immunology
#111
of 275 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 31,520 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one is in the 36th percentile – i.e., 36% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 250,100 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 31st percentile – i.e., 31% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 275 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.